Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Mirati Therapeutics Receives Positive Opinion From CHMP For Krazati (Adagrasib) As A Targeted Treatment Option For Patients With Advanced Non-small Cell Lung Cancer With A KRASG12C Mutation Following A Re-examination Procedure

Author: Benzinga Newsdesk | November 10, 2023 08:45am

Posted In: MRTX